Kinetics and polarity effects in the synthesis of the ionic liquid, 1-hexyl-3-methyl-imidazolium bromide, using compressed CO sub(2)

Compressed carbon dioxide, as a solvent medium, offers unique benefits for the synthesis of ionic liquids (ILs) especially for the ability to combine reaction and separation. The second-order reaction rate constants were determined for the synthesis of 1-hexyl-3-methylimidazolium bromide ([HMIm][Br]...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of supercritical fluids 2015-01, Vol.96, p.171-179
Hauptverfasser: Nwosu, Sylvia O, Schleicher, Jay C, Scurto, Aaron M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compressed carbon dioxide, as a solvent medium, offers unique benefits for the synthesis of ionic liquids (ILs) especially for the ability to combine reaction and separation. The second-order reaction rate constants were determined for the synthesis of 1-hexyl-3-methylimidazolium bromide ([HMIm][Br]) at 313.15 K and 333.15 K and 30-150 bar from the reactants, 1-methylimidazole and 1-bromohexane. Two different scenarios were encountered based upon the pressure: a one-phase supercritical mixture of the reactants becoming a vapor-liquid IL/CO sub(2) system at complete conversion; or a two-phase CO sub(2)-expanded liquid (CXL) that yielded a three-phase vapor-liquid-liquid equilibrium (VLLE) at intermediate conversions. Despite multiphase phenomena, the vast majority of the reaction occurs in the reactant-rich liquid phase. The kinetic rate constants were comparable with traditional organic solvents. The reaction rates were higher in the CXL mode than in the initially supercritical mixtures. The changes in the kinetic rate constant with pressure (CO sub(2) composition) could be explained and quantified using Kamlet-Taft (KT) polarity parameters that were measured in the mixtures using solvatochromic probes.
ISSN:0896-8446
DOI:10.1016/j.supflu.2014.10.002